# OverT Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/overt-bio

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.overt.bio/
- Total disclosed funding: $12M
- Latest round: Seed (May 9, 2024)
- Investors on record: 9

## About

Founded in 2022 by co-founders Mat Legut and Neville Sanjana and based in New York, the US, OverT Bio is developing cellular therapies for solid tumours. The company utilizes platforms to engineer immune cells for effective and safe cancer treatment. In May 2024, OverT Bio, Inc. raised USD 16 million in seed funding co-led by investors ARTIS Ventures and Wing, with participation from other investors Fusion Fund, OMX Ventures, Alexandria Venture Investments, Gaingels, Civilization Ventures, Hawktail Management, and Cancer Research Institute.

OverT Bio focuses on the research and development of cellular therapies for solid tumors. The work centers on engineering immune cells, specifically T cells, to cure cancer. The company uses its proprietary platforms, OverTarget and OverTune, for pooled functional screening and synthetic genomics to develop these engineered immune cells. OverTarget involves a method for large-scale functional screening to identify genes or pathways that can enhance T cell activity against cancer cells. OverTune is a platform for synthetic genomics, allowing for precise genetic modifications in T cells to improve their targeting and anti-tumor function.

The company will use the May 2024 funding to further expand its platform.

## Funding rounds

- Seed, May 9, 2024, $12M — Alexandria Venture Investments, ARTIS Ventures, Wing, Fusion Fund, Gaingels, Civilization Ventures, OMX Ventures, Hawktail, Cancer Research Institute

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Seed
- ARTIS Ventures (https://capitalatlas.ai/funds/artis-ventures) — Seed
- Wing (https://capitalatlas.ai/funds/wing) — Seed
- Fusion Fund (https://capitalatlas.ai/funds/fusion-fund) — Seed
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Seed
- Civilization Ventures (https://capitalatlas.ai/funds/civilization-ventures) — Seed
- OMX Ventures (https://capitalatlas.ai/funds/omx-ventures) — Seed
- Hawktail (https://capitalatlas.ai/funds/hawktail) — Seed
- Cancer Research Institute — Seed